33 results
424B5
BDTX
Black Diamond Therapeutics Inc
30 Jun 23
Prospectus supplement for primary offering
4:01pm
the disposition, which may be offset by certain U.S.-source capital losses of the non-U.S. holder, if any, provided the non-U.S. holder has timely filed U.S
424B5
BDTX
Black Diamond Therapeutics Inc
29 Jun 23
Prospectus supplement for primary offering
6:02am
of residence) on the net gain derived from the disposition, which may be offset by certain U.S.-source capital losses of the non-U.S. holder, if any
S-3
e1lw4l
14 Nov 22
Shelf registration
4:15pm
S-3
pso1o
14 Nov 22
Shelf registration
4:15pm
DEFA14A
c2c02q9l a4
29 Apr 21
Additional proxy soliciting materials
4:04pm
DEF 14A
oyp6t
27 Apr 21
Definitive proxy
4:06pm
S-3ASR
opnpf3
1 Feb 21
Automatic shelf registration
5:28pm